Literature DB >> 17885882

Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.

Ada Trindade de Almeida1, Koenraad De Boulle.   

Abstract

Over the past decade, growth in the number and types of aesthetic procedures performed using botulinum neurotoxin has increased, along with the number of these products. As more options, along with emerging counterfeit agents, become available to clinicians, differences among preparations need to be considered in order to ensure optimal outcomes for patients. Once injected into the muscle, botulinum neurotoxin distributes within that tissue to produce the desired local effects. Diffusion, or the distribution of product beyond the target muscle, can be of concern because of the potential for local and systemic effects that result in muscle weakening away from the desired site. Several factors influence diffusion, including preparation characteristics (e.g. molecular size and structure), dosing and injection technique, and muscles injected. In this article, we discuss the accumulating preclinical and clinical data that differentiate botulinum neurotoxin agents with respect to their diffusion characteristics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885882     DOI: 10.1080/17429590701523794

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  18 in total

1.  Duration of action of abobotulinumtoxina and onabotulinumtoxina: a randomized, double-blind study using a contralateral frontalis model.

Authors:  Mark S Nestor; Glynis R Ablon
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  The Retaining Ligament of the Anterior Digastric Muscle.

Authors:  Matthew J Zdilla; Jordan V Swearingen; Kyle D Miller; Adam Bender-Heine; H Wayne Lambert
Journal:  J Craniofac Surg       Date:  2017-03       Impact factor: 1.046

Review 3.  Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.

Authors:  Marco Pirazzini; Ornella Rossetto; Roberto Eleopra; Cesare Montecucco
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

Review 4.  Clinical uses of botulinum toxin A in smile aesthetic modification.

Authors:  S N Delpachitra; A W Sklavos; M Dastaran
Journal:  Br Dent J       Date:  2018-09-28       Impact factor: 1.626

5.  Neuromodulator threading: revisiting an approach to neurotoxin delivery.

Authors:  H William Higgins; Kachiu C Lee; Yoash Enzer
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

6.  Do complexing proteins provide mechanical protection for botulinum neurotoxins?

Authors:  Dirk Dressler; Lizhen Pan; Fereshte Adib Saberi; Hans Bigalke
Journal:  J Neural Transm (Vienna)       Date:  2019-06-06       Impact factor: 3.575

Review 7.  Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.

Authors:  Koenraad De Boulle; Steven Fagien; Boris Sommer; Richard Glogau
Journal:  Clin Interv Aging       Date:  2010-04-26       Impact factor: 4.458

Review 8.  A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses.

Authors:  James P Bonaparte; David Ellis; Jason G Quinn; Mohammed T Ansari; Jessica Rabski; Shaun J Kilty
Journal:  Syst Rev       Date:  2013-06-13

9.  Differential characteristics of incobotulinumtoxinA and its use in the management of glabellar frown lines.

Authors:  Welf Prager
Journal:  Clin Pharmacol       Date:  2013-03-12

10.  Diffusion of botulinum toxins.

Authors:  Matthew A Brodsky; David M Swope; David Grimes
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.